在肝细胞癌中对免疫疗法的耐药性机制
Giulia Francesca Manfredi1,2, Ciro Celsa1,3,4, Chloe John1
1Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.
Journal of hepatocellular carcinoma
|November 9, 2023
概括
免疫检查点抑制剂 (ICI) 已经改变了晚期肝癌的治疗方法. 然而,耐药性限制了它们的有效性,需要研究克服这些挑战以获得更好的患者结果.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 免疫治疗是一种免疫疗法.
- 癌症抵抗机制 癌症抵抗机制
背景情况:
- 晚期肝细胞癌 (HCC) 的全身治疗已被免疫检查点抑制剂 (ICI) 显著改善.
- 虽然ICI组合提供了生存益处,但并非所有患者都对ICI有反应,理想的ICI伴侣是未知的.
- 用ICI单疗已显示出有限的疗效,突出需要了解耐药性.
研究的目的:
- 审查已知的免疫检查点抑制剂耐药性机制在先进的HCC.
- 探索潜在的治疗策略来克服ICI耐药性.
- 确定未来改善HCC免疫疗法反应的方向.
主要方法:
- 在ICI治疗的HCC中对抗性机制的文献综述.
- 分析内在 (癌细胞) 和外在 (瘤微环境) 抵抗因子.
- 讨论克服抗性的治疗方法.
主要成果:
- 多种内在和外在机制有助于HCC的ICI耐药性.
- 治疗因素也可以影响耐药性的发展.
- 目前正在研究新的方法来提高ICI的疗效.
结论:
- 了解抵抗机制对于推进HCC免疫疗法至关重要.
- 针对抗药性途径提供了改善患者生存的潜力.
- 未来的研究应该集中在组合疗法和新的目标,以克服ICI耐药性.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
相关概念视频
Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cytotoxic T Cells-mediated Immune Response
928
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
928
Cell-mediated Immune Responses
68.6K
Overview
68.6K
